Leucylglycinamide Released from Oxytocin by Human Uterine Enzyme

  • Roderich Walter
    Departments of Physiology and Obstetrics and Gynecology, Mount Sinai Medical and Graduate Schools, City University of New York, New York 10029
  • H. Shlank
    Departments of Physiology and Obstetrics and Gynecology, Mount Sinai Medical and Graduate Schools, City University of New York, New York 10029
  • J. D. Glass
    Departments of Physiology and Obstetrics and Gynecology, Mount Sinai Medical and Graduate Schools, City University of New York, New York 10029
  • I. L. Schwartz
    Departments of Physiology and Obstetrics and Gynecology, Mount Sinai Medical and Graduate Schools, City University of New York, New York 10029
  • T. D. Kerenyi
    Departments of Physiology and Obstetrics and Gynecology, Mount Sinai Medical and Graduate Schools, City University of New York, New York 10029

抄録

<jats:p>Uteri of pregnant and nonpregnant women contain enzymic activities which inactivate oxytocin. A potent enzyme, which has been partially purified from uterine homogenates, cleaves the prolyl-leucyl peptide bond of oxytocin. This finding associates for the first time the release of the dipeptide leucylglycinamide with the degradation of neurohypophyseal hormones.</jats:p>

収録刊行物

  • Science

    Science 173 (3999), 827-829, 1971-08-27

    American Association for the Advancement of Science (AAAS)

被引用文献 (18)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ